Boston Scientifics Pivotal Trial Shows Over 93 Success Rate for Device VLYPP Q1 2026 Earnings Preferred EPS Beats Estimates Despite Marginal Stock Decline Natural Gas Futures Decline as Weather Forecasts Turn Milder